Chatchai Phoomak
Bangkok, Thailand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Glucosamine induces apoptosis of cholangiocarcinoma cells by suppressing high-mannose type N-glycosylation and EGFR/STAT3 signaling.
Journal: Future science OA
Published: March 09, 2026
Asparagine-linked glycosylation protein 1 (ALG1) promotes aggressive phenotypes of lung adenocarcinoma cells, A549, via modulating N-linked glycosylation and ER-Stress.
Journal: Glycoconjugate journal
Published: June 26, 2025
Pro-Tumorigenic Roles of Cyclin Dependent Kinase 2 and its Associated Cyclins in Cholangiocarcinoma Progression under High Glucose Condition.
Journal: Archives of medical research
Published: May 14, 2025
Loss of JAK1 Function Causes G2-M Cell-Cycle Defects Vulnerable to KIF18A Inhibition.
Journal: Cancer research
Published: March 30, 2025
Loss of JAK1 Function Causes G2/M Cell Cycle Defects Vulnerable to Kif18a Inhibition.
Journal: bioRxiv : the preprint server for biology
Published: March 10, 2025
OST Catalytic Subunit Redundancy Enables Therapeutic Targeting of N-Glycosylation.
Journal: bioRxiv : the preprint server for biology
Published: December 16, 2024
Redundancy of the OST catalytic subunit facilitates therapeutic targeting of N-glycosylation.
Journal: Cell chemical biology
Published: June 12, 2024
Combined analysis of secreted proteins and glycosylation identifies prognostic features in cholangiocarcinoma.
Journal: Journal of cellular physiology
Published: May 07, 2023
Signal recognition particle receptor-β (SR-β) coordinates cotranslational N-glycosylation.
Journal: Science advances
Published: March 15, 2023
Hyperglycemia Alters O-GlcNAcylation Patterns of Hepatocytes in Mice Treated With Hepatoxic Carcinogen.
Journal: In vivo (Athens, Greece)
Published: January 17, 2023
Last Updated: 09/26/2026